The surgeon's crucial role in the era of transcatheter aortic valve replacement:lifetime management
10.3969/j.issn.1004-8812.2025.04.007
- VernacularTitle:经导管主动脉瓣置换术时代外科医师的重任:全生命周期管理
- Author:
Tong TAN
1
;
En-jun ZHU
1
;
Hao CUI
1
;
Yong-qiang LAI
1
Author Information
1. 首都医科大学附属北京安贞医院心脏外科中心 北京市心肺血管疾病研究所,北京 100029
- Publication Type:Journal Article
- Keywords:
Transcatheter aortic valve replacement;
Surgical aortic valve replacement;
Interventional therapy;
Lifetime management;
Valve durability
- From:
Chinese Journal of Interventional Cardiology
2025;33(4):227-230
- CountryChina
- Language:Chinese
-
Abstract:
Transcatheter aortic valve replacement(TAVR)is increasingly being applied in low-risk and younger patients.However,this trend necessitates that cardiac surgeons take on the responsibility of comprehensive lifetime management.This article explores three critical aspects of lifetime management,including the selection of the initial valve,the procedural success and the device success rates of TAVR,and the durability of the valve.Younger TAVR recipients require comprehensive lifetime management strategies,including the potential risk of reintervention.Improving TAVR's procedural and device success rates is the cornerstone of lifetime management,necessitating efforts in surgical strategy and operation to reduce complications.Valve durability is a key guarantee;current surgical bioprosthetic valves show good durability,but long-term data on TAVR valves'durability is still needed.Meanwhile,novel valves are being improved in durability,offering new directions for optimizing lifetime management in TAVR patients.